Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.

Pharmacogenomics - 1 Feb 2013

Weng Liming, Zhang Li, Peng Yan, Huang R Stephanie

Abstract excerpt

In the past decade, advances in pharmacogenetics and pharmacogenomics (PGx) have gradually unveiled the genetic basis of interindividual differences in drug responses. A large portion of these advances have been made in the field of anticancer therapy. Currently, the US FDA has updated the package inserts of approximately 30 anticancer agents to include PGx information. Given the complexity of this genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Capecitabine
Share to Deoxycytidine
Share to Drug Discovery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorouracil

Share to Mercaptopurine

Share to Methyltransferases

Share to Pharmacogenetics

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 23394393
DOI: 10.2217/pgs.12.213
PMCID: PMC3605891

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.PMID 23394393Read ↗

Application of pharmacogenetics in oncologySemantic proximity Read ↗

Pharmacogenetics and pharmacogenomics of anticancer agents.Semantic proximity Read ↗

Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectivesSemantic proximity Read ↗

Pharmacogenetics and cancer therapy.Semantic proximity Read ↗

Cancer Pharmacogenomics: Early Promise, But Concerted Effort NeededSemantic proximity Read ↗

Germline oncopharmacogenetics, a promising field in cancer therapy.Semantic proximity Read ↗

Pharmacogenomics in Solid Tumors: A Comprehensive Review of Genetic Variability and Its Clinical ImplicationsSemantic proximity Read ↗

Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.Semantic proximity Read ↗

Cancer pharmacogeneticsSemantic proximity Read ↗

Cancer pharmacogenetics.Semantic proximity Read ↗

Clinically relevant cancer biomarkers and pharmacogenetic assays.Semantic proximity Read ↗

Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.